Lindsay A MD Rosenwald's Net Worth
$74.6 Million
Who is Lindsay A MD Rosenwald?
Lindsay A MD Rosenwald has an estimated net worth of $74.6 Million. This is based on reported shares across multiple companies, which include ZIOPHARM ONCOLOGY INC, MANHATTAN PHARMACEUTICALS INC, NATIONAL HOLDINGS CORP, CB Pharma Acquisition Corp., Fortress Biotech, Inc., AVENUE THERAPEUTICS, INC., MUSTANG BIO, INC., Checkpoint Therapeutics, Inc., KERYX BIOPHARMACEUTICALS INC, Journey Medical Corp, GENTA INC DE/, INTRAC INC, Innovive Pharmaceuticals, Inc., Cougar Biotechnology, Inc., SITKA SCIENCES, INC., SEWARD SCIENCES, INC., NORTON SOUND ACQUISITION CORP., KODIAK SCIENCES, INC., KANAI SCIENCES, INC., DENALI SCIENCES, INC., CORDOVA SCIENCES, INC., CHITINA SCIENCES, INC., BRISTOL BAY SCIENCES, INC., ARCTIC ACQUISITION CORP., Paramount Acquisition Corp, NOVADEL PHARMA INC, CYPRESS BIOSCIENCE INC, and DOR BIOPHARMA INC.
SEC CIK
Lindsay A MD Rosenwald's CIK is 0000941841
Past Insider Trading and Trends
2005 was Lindsay A MD Rosenwald's most active year for acquiring shares with 82 total transactions. Lindsay A MD Rosenwald's most active month to acquire stocks was the month of December. 2006 was Lindsay A MD Rosenwald's most active year for disposing of shares, totalling 4 transactions. Lindsay A MD Rosenwald's most active month to dispose stocks was the month of May. 2023 saw Lindsay A MD Rosenwald paying a total of $5,378,051.02 for 7,442,937 shares, this is the most they've acquired in one year. In 2009 Lindsay A MD Rosenwald cashed out on 265,538 shares for a total of $9,594,245.33, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZIOPHARM ONCOLOGY INC (TCRT) Snapshot price: $2.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MANHATTAN PHARMACEUTICALS INC (TGTX) Snapshot price: $22.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +0.20% | 5K |
$1.55 | $7,750.00 | 2.56M |
Apr 1
| |||
Form 4
| +0.19% | 5K |
$1.56 | $7,800.00 | 2.65M |
May 11
| |||
Form 4
| +0.19% | 5K |
$1.50 | $7,500.00 | 2.64M |
May 9
| |||
Form 4
| +0.19% | 5K |
$1.40 | $7,010.00 | 2.64M |
May 4
| |||
Form 4
| +0.19% | 5K |
$1.35 | $6,750.00 | 2.63M |
May 3
| |||
Form 4
| +0.19% | 5K |
$1.25 | $6,250.00 | 2.63M |
Apr 28
| |||
Form 4
| +0.19% | 5K |
$1.34 | $6,700.00 | 2.62M |
Apr 27
| |||
Form 4
| +0.19% | 5K |
$1.46 | $7,300.00 | 2.62M |
Apr 26
| |||
Form 4
| +0.19% | 5K |
$1.48 | $7,400.00 | 2.61M |
Apr 25
| |||
Form 4
| +0.19% | 5K |
$1.50 | $7,500.00 | 2.61M |
Apr 22
| |||
Form 4
| +0.19% | 5K |
$1.53 | $7,650.00 | 2.6M |
Apr 21
| |||
Form 4
| +0.19% | 5K |
$1.50 | $7,500.00 | 2.6M |
Apr 19
| |||
Form 4
| +0.19% | 5K |
$1.50 | $7,500.00 | 2.59M |
Apr 15
| |||
Form 4
| +0.19% | 5K |
$1.57 | $7,850.00 | 2.59M |
Apr 14
| |||
Form 4
| +0.39% | 10K |
$1.58 | $15,800.00 | 2.58M |
Apr 12 - Apr 13
| |||
Form 4
| +0.19% | 5K |
$1.60 | $8,000.00 | 2.57M |
Apr 8
| |||
Form 4/A
| +0.20% | 5K |
$1.55 | $7,750.00 | 2.56M |
Apr 1
| |||
Form 4
| +0.19% | 5K |
$1.56 | $7,800.00 | 2.57M |
Apr 7
| |||
Form 4
| +0.20% | 5K |
$1.55 | $7,750.00 | 2.56M |
Apr 1
| |||
Form 4
| +0.07% | 1.7K |
$1.40 | $2,380.00 | 2.56M |
Mar 30
| |||
Form 4
| +0.20% | 5K |
$1.46 | $7,280.00 | 2.56M |
Mar 29
| |||
Form 4
| +0.20% | 5K |
$1.50 | $7,500.00 | 2.55M |
Mar 28
| |||
Form 4
| +0.20% | 5K |
$1.60 | $8,000.00 | 2.55M |
Mar 24
| |||
Form 4
| +0.02% | 500 |
$1.53 | $765.00 | 2.54M |
Mar 22
| |||
Form 4
| +0.20% | 5K |
$1.60 | $8,000.00 | 2.54M |
Mar 18
| |||
Form 4
| +0.20% | 5K |
$1.60 | $8,000.00 | 2.54M |
Mar 17
| |||
Form 4
| +0.20% | 5K |
$1.70 | $8,500.00 | 2.53M |
Mar 8
| |||
Form 4
| +0.20% | 5K |
$2.10 | $10,500.00 | 2.53M |
Mar 1
| |||
Form 4
| +0.20% | 5K |
$1.69 | $8,450.00 | 2.52M |
Feb 25
| |||
Form 4
| +0.20% | 5K |
$1.51 | $7,550.00 | 2.52M |
Feb 18
| |||
Form 4
| +0.20% | 5K |
$1.54 | $7,700.00 | 2.51M |
Feb 17
| |||
Form 4
| +0.20% | 5K |
$1.52 | $7,600.00 | 2.51M |
Feb 16
| |||
Form 4
| +0.20% | 5K |
$1.55 | $7,750.00 | 2.5M |
Feb 14
| |||
Form 4
| +0.20% | 5K |
$1.50 | $7,500.00 | 2.5M |
Feb 10
| |||
Form 4
| +0.26% | 6.5K |
$1.51 | $9,815.00 | 2.49M |
Feb 8
| |||
Form 4
| +0.40% | 10K |
$1.40 | $14,000.00 | 2.49M |
Feb 7
| |||
Form 4
| +0.41% | 10K |
$1.38 | $13,800.00 | 2.48M |
Feb 4
| |||
Form 4
| +0.41% | 10K |
$1.41 | $14,100.00 | 2.47M |
Feb 2
| |||
Form 4
| +0.41% | 10K |
$1.49 | $14,900.00 | 2.46M |
Feb 1
| |||
Form 4
| +0.41% | 10K |
$1.40 | $14,000.00 | 2.45M |
Jan 31
| |||
Form 4
| +0.41% | 10K |
$1.31 | $13,100.00 | 2.44M |
Jan 28
| |||
Form 4
| +0.73% | 17.5K |
$1.36 | $23,725.00 | 2.43M |
Jan 24
| |||
Form 4
| +0.95% | 22.6K |
$1.30 | $29,392.00 | 2.41M |
Jan 21
| |||
Form 4
| +1.06% | 25K |
$1.04 | $26,000.00 | 2.39M |
Jan 20
| |||
Form 4
| +0.43% | 10K |
$1.06 | $10,600.00 | 2.36M |
Jan 19
| |||
Form 4
| +0.43% | 10K |
$1.00 | $10,000.00 | 2.35M |
Jan 18
| |||
Form 4
| +0.43% | 10K |
$1.03 | $10,300.00 | 2.34M |
Jan 14
| |||
Form 4
| +0.43% | 10K |
$1.03 | $10,300.00 | 2.33M |
Jan 13
| |||
Form 4
| +0.43% | 10K |
$1.06 | $10,600.00 | 2.32M |
Jan 12
| |||
Form 4
| +1.32% | 30K |
$1.05 | $31,625.00 | 2.31M |
Jan 7 - Jan 10
| |||
Form 4
| +0.44% | 10K |
$1.04 | $10,400.00 | 2.28M |
Jan 6
| |||
Form 4
| +0.44% | 10K |
$0.94 | $9,365.00 | 2.27M |
Oct 13 - Oct 14
| |||
Form 4
| +0.44% | 10K |
$0.89 | $8,900.00 | 2.26M |
Oct 4
| |||
Form 4
| +0.45% | 10K |
$0.94 | $9,410.00 | 2.25M |
Sep 28
| |||
Form 4
| +0.95% | 21K |
$0.84 | $17,600.00 | 2.24M |
Aug 17 - Sep 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NATIONAL HOLDINGS CORP No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CB Pharma Acquisition Corp. No price found
Co-Chairman and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -79.38% | -1.02M |
—
|
—
| 265K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
| -7.22% | -100.00K |
—
|
—
| 1.28M |
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fortress Biotech, Inc. (FBIO) Snapshot price: $1.79
President, CEO & Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.08% | 5K |
$7.48 | $37,417.50 | 127.5K |
Jul 11
| |||
Form 4
| +4.26% | 5K |
$7.39 | $36,971.00 | 122.5K |
Jul 9
| |||
Form 4
| +4.44% | 5K |
$7.35 | $36,764.50 | 117.5K |
Jul 8
| |||
Form 4
| +0.70% | 20K |
$1.64 | $32,724.00 | 2.89M |
Jun 28
| |||
Form 4
| +0.35% | 10K |
$1.76 | $17,589.00 | 2.87M |
May 16
| |||
Form 4
| +1.78% | 50K |
$2.38 | $118,770.00 | 2.86M |
Jan 5
| |||
Form 4
| +8.33% | 216.47K |
—
|
—
| 2.81M |
Jan 1
| |||
Form 4
| +152.20% | 1.57M |
$1.70 | $2,664,775.50 | 2.6M |
Nov 14
| |||
Form 4
| +0.65% | 100K |
$0.28 | $28,330.00 | 15.45M |
Sep 26
| |||
Form 4
| +21.62% | 20K |
$10.55 | $210,900.00 | 112.5K |
Aug 17 - Aug 18
| |||
Form 4
| +18.49% | 2.4M |
$0.84 | $1,999,999.52 | 15.35M |
Feb 10
| |||
Form 4
| +10.43% | 1.22M |
$0.73 | $3,112.72 | 12.95M |
Jun 1 - Jan 1
| |||
Form 4
| +0.86% | 100K |
$0.68 | $67,960.00 | 11.73M |
Dec 1
| |||
Form 4
| +0.04% | 5K |
$0.56 | $2,800.00 | 11.63M |
Nov 30
| |||
Form 4
| +0.87% | 100K |
$0.70 | $69,500.00 | 11.63M |
Oct 21
| |||
Form 4
| +10.75% | 1.12M |
$2.36 | $6,021.07 | 11.53M |
Jun 1 - Jan 1
| |||
Form 4
| +11.02% | 1.03M |
$1.97 | $5,632.38 | 10.41M |
Jun 1 - Jan 1
| |||
Form 4
| +131.25% | 52.5K |
$18.00 | $945,000.00 | 92.5K |
Aug 26
| |||
Form 4
| +9.38% | 804.13K |
$1.52 | $3,927.08 | 9.37M |
Jun 3 - Jan 1
| |||
Form 4
| +4.86% | 396.82K |
$1.26 | $499,999.50 | 8.57M |
Jul 18
| |||
Form 4
| +20.68% | 1.4M |
—
|
—
| 8.17M |
Jan 1 - Jan 1
| |||
Form 4
|
∞
| 40K |
$25.00 | $1,000,000.00 | 40K |
Nov 6
| |||
Form 4
| +10.43% | 553.43K |
$2.03 | $1,483.93 | 5.86M |
Dec 1 - Jan 1
| |||
Form 4
| +0.01% | 613 |
$2.40 | $1,471.20 | 5.3M |
Jun 1
| |||
Form 4
| +10.65% | 510.43K |
—
|
—
| 5.3M |
Jan 1
| |||
Form 4
| +0.01% | 586 |
$2.41 | $1,412.26 | 4.79M |
Dec 1
| |||
Form 4
| +0.02% | 785 |
$1.80 | $1,413.00 | 4.79M |
Jun 1
| |||
Form 4
| +0.02% | 974 |
$1.45 | $1,412.30 | 4.79M |
Dec 1
| |||
Form 4
| +3.23% | 150K |
$1.61 | $241,500.00 | 4.79M |
Nov 6
| |||
Form 4/A
| +0.08% | 2K |
$6.95 | $13,900.00 | 2.46M |
Jan 23
| |||
Form 4
| +74.44% | 1.98M |
—
|
—
| 4.64M |
Dec 19
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| +8.13% | 200K |
$5.00 | $1,000,000.00 | 2.66M |
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4/A
| +0.08% | 2K |
$6.95 | $13,900.00 | 2.46M |
Jan 22 - Jan 23
| |||
Form 4
| +0.08% | 2K |
$6.95 | $13,900.00 | 2.43M |
Jan 23
| |||
Form 4
| +0.08% | 2K |
$5.66 | $11,320.00 | 2.42M |
Jan 20
| |||
Form 4
| +0.08% | 2K |
$5.67 | $11,340.00 | 2.42M |
Jan 19
| |||
Form 4
| +0.08% | 2K |
$5.66 | $11,320.00 | 2.42M |
Jan 18
| |||
Form 4
| +0.08% | 2K |
$5.40 | $10,800.00 | 2.42M |
Jan 17
| |||
Form 4
| +0.08% | 2K |
$5.40 | $10,800.00 | 2.42M |
Jan 13
| |||
Form 4
| +0.17% | 4K |
$5.35 | $21,380.00 | 2.41M |
Jan 11 - Jan 12
| |||
Form 4
| +0.08% | 2K |
$7.00 | $14,000.00 | 2.41M |
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||